Search

Your search keyword '"Schotten, Ulrich"' showing total 1,170 results

Search Constraints

Start Over You searched for: Author "Schotten, Ulrich" Remove constraint Author: "Schotten, Ulrich"
1,170 results on '"Schotten, Ulrich"'

Search Results

2. Genetic architecture of spatial electrical biomarkers for cardiac arrhythmia and relationship with cardiovascular disease.

5. Compartmentalization proteomics revealed endolysosomal protein network changes in a goat model of atrial fibrillation

7. An angiopoietin 2, FGF23, and BMP10 biomarker signature differentiates atrial fibrillation from other concomitant cardiovascular conditions

12. Atrial fibrillation-specific refinement of the STOP-Bang sleep apnoea screening questionnaire: insights from the Virtual-SAFARI study

13. Repurposing catheter ablation work-up to detect expiratory airflow limitation in patients with atrial fibrillation

17. Lysosomal signalling pathways influence heart rhythm, and regulate atrial function

18. Atrial fibrillation in the presence and absence of heart failure enhances expression of genes involved in cardiomyocyte structure, conduction properties, fibrosis, inflammation, and endothelial dysfunction

20. Genetic analyses of the electrocardiographic QT interval and its components identify additional loci and pathways

21. Healthcare utilisation and quality of life according to atrial fibrillation burden, episode frequency and duration.

22. Analysis of drug-induced and spontaneous cardioversions reveals similar patterns leading to termination of atrial fibrillation.

24. Blood-based cardiometabolic phenotypes in atrial fibrillation and their associated risk: EAST-AFNET 4 biomolecule study

25. Oral anticoagulation in device-detected atrial fibrillation: effects of age, sex, cardiovascular comorbidities, and kidney function on outcomes in the NOAH-AFNET 6 trial

26. Longer and better lives for patients with atrial fibrillation: the 9th AFNET/EHRA consensus conference

30. Anticoagulation with edoxaban in patients with long atrial high-rate episodes ≥24 h

32. Longer and better lives for patients with atrial fibrillation:the 9th AFNET/EHRA consensus conference

33. Longer and better lives for patients with atrial fibrillation : the 9th AFNET/EHRA consensus conference

34. Safety and efficacy of long-term sodium channel blocker therapy for early rhythm control: the EAST-AFNET 4 trial.

36. Disturbed atrial metabolism, shear stress, and cardiac load AF after ablation: AXAFA biomolecule study

37. Women have less progression of paroxysmal atrial fibrillation: data from the RACE V study

38. Heart Failure, Female Sex, and Atrial Fibrillation Are the Main Drivers of Human Atrial Cardiomyopathy: Results From the CATCH ME Consortium

39. Anticoagulation with edoxaban in patients with long Atrial High-Rate Episodes ≥24 hours

43. Disturbed atrial metabolism, shear stress, and cardiac load contribute to atrial fibrillation after ablation: AXAFA biomolecule study.

44. Detection of brain lesions after catheter ablation depends on imaging criteria – Insights from AXAFA-AFNET 5 trial

45. Anticoagulation with Edoxaban in Patients with Atrial High-Rate Episodes

49. PO-02-144 ETIOLOGICAL AND MOLECULAR DETERMINANTS OF ATRIAL ENDOMYSIAL FIBROSIS: RESULTS FROM THE CATCH ME CONSORTIUM

50. MP-453085-5 ATRIAL FIBRILLATION, FEMALE SEX AND HEART HAILURE ARE THE MAIN DRIVERS OF ATRIAL CARDIOMYOPATHY IN CARDIAC SURGERY PATIENTS: RESULTS FROM THE CATCH ME CONSORTIUM

Catalog

Books, media, physical & digital resources